To identify choliinergically mediated components in the optic nerve response (ONR) we studied effects of cholinergic agonists and antagonists in the arterially perfused cat eye. Acetyleholine, carbachol, scopolamine, quinuclidinylbenzilate and mecamylamine were applied intra-arterially in micromolar concentrations. Recordings of rod-and cone-driven ERG accompanied those of the ONR and revealed: (i) cholinergic agonists enhanced the b-wave, particularly under photopic conditions, whereas scopolamine decreased the b-wave. Mecamylamine induced biphasic effects (decrease followed by increase) in the amplitudes of the rod-and cone-driven b-waves. The effects on the cone-driven ERG were more marked than those on the rod-driven ERG. 
INTRODUCTION
Cholinergic neurons haw~ been identified in a variety of mammalian retinae (Puro, 1985) , such as rabbit (Masland, 1980; Tauchi & Masland, 1984) , cat (Pourcho & Osman, 1986; Pourcho & Osman, 1987; Schmidt, Humphrey & W/issle, 1987) , rat (Eckenstein, Schwab & Thoenen, 1981) and human (Hutchins & Hollyfield, 1987) . Both nicotinic and muscarinic receptors have been shown (Pourcho & Osman, 1987; Zarbin, Wamsley, Palacios & Kumar, 1986) . The consistent morphological features suggest a significant physiological role of the *The data have, in part, been presented at ARVO, May 1994 cholinergic systems in mammalian retina. However, electrophysiological studies on the function of acetylcholine (ACh) and effects of cholinergic and anticholinergic drugs in the retina revealed partly controversial results: several authors reported ACh mediated inhibitory effects on ON-centre ganglion cells and excitatory effects on OFF-centre ganglion cells (Straschill, 1967; Straschill & Perwein, 1973) , while others reported that ACh predominantly increases the light-evoked activity of Y cells (with a periphery effect), but not of X cells (Ikeda & Sheardown, 1982) . Strong cholinergic input was shown in ON and ON/OFF directional sensitive ganglion cells that costratify with cholinergic amacrine cells in the rabbit (Masland & Ames, 1976; Famiglietti, 1983) . In addition, a spontaneous, light-independent release of ACh was suggested (Ariel & Daw, 1982a; Masland, 1982) , and ACh was found to regulate the level of ganglion cell maintained activity in the rabbit retina (Ariel & Daw, 1982a; Ariel & Daw, 1982b) . Schmidt et al. (1987) observed that ACh increased the light-induced FIGURE 1, Effects of cholinergic agents on the rod-driven b-wave: the time-course of changes in normalized amplitudes of the rod-driven b-wave is plotted in response to ACh (A), to scopolamine 03) and to mecamylamine (C). The changes are plotted as a percentage of the control values (100%). ERGs were evoked every 60 sec by 400 msec flashes using a long wavelength band filter matched to a corresponding short wavelength band filter, attenuated by 3-4 log units with neutral density filters for selective rod stimulation. The beginning of the changes in response to cholinergic agents was set at 0 rain, and the duration of injection was adjusted to the time to reach a steady state in this and subsequent figures. ACh (A) (18--1600/zM) was injected for 10-35 vain and induced, although with some variability, an increase in b-wave up to 200%. ERG traces, control and 400/aM ACh, cal. 100/aV. Scopolamine (B) (210-1000/aM) was injected for 17 mill. Concentrations in the range of 500-1000/aM usually induced a decrease in b-wave by 20-40%. Mecamylamine (C) (120-1000/aM) was injected for 10-17 rain. The b-wave was clearly decreased up to 40% by concentrations above 120 #M.
and spontaneous activity of all ON-and OFF-, X-and Ycells. The primary goal of the present study was to detect an expression of cholinergic activity and to assess qualitatively its relative functional weight in the light-evoked compound action potential of the optic nerve [optic nerve response (ONR)]. In parallel, effects of cholinergic agonists and antagonists on the b-wave of the ERG were recorded. We used the isolated arterially perfused cat eye preparation to study effects of cholinergic agents on retinal function. This in vitro preparation comprised the following advantages: (i) the chemical input to the perfused eye can be controlled; (ii) systemic variables and extraocular metaboli,;m are excluded; (iii) ERG and ONR can be recorded simultaneously to ascribe effects to the outer or inner retinal !layers, respectively; (iv) effects of chemical agents on the retina can be assessed in the presence of intact retinal pigment epithelium and retinal vascular system (Niemeyer, 1981) . It will become evident that cholinergic agonists and antagonists modulate the light-evoked electrical field responses, providing further physiologiical evidence of powerful contribution of cholinergic mechanisms in retinal signal processing.
METHODS
The experiments were ,carded out on 13 cats (16 eyes) and in accordance with the ARVO resolution on the use of animals in research and with the regulations of the cantonal veterinary authority of Ziirich. The details on the method (anaesthesia, application of drugs to the perfused cat eye and :signal recordings) have been published previously (Niemeyer, 1981; Niemeyer, 1992; Uji & Niemeyer, 1989) .
Anaesthesia
After premedication with atropine sulphate (0.02-0.04 mg/kg body wt s.c.) and ketamine hydrochloride (Ketalar, 10-20mg/kg body wt, i.m.) the cats were intubated, paralysed by gallamine triethiodide (Flaxedil, i.v.) and anaesthetized with pentobarbital hydrochloride (Nembutal, Abbott Lab., North Chicago, IL., 9-16 mg/kg body wt, i.v.). Muscle relaxation and deep anaesthesia were maintained by continuous pump driven i.v. application of gallamine triethiodide and pentobarbital hydrochloride, respectively (Hirsch-Hoffmann & Niemeyer, 1994) . Prior to surgical procedures, fentanyl (0.05 mg i.v., Janssen, Baar, Switzerland) was applied to ensure complete analgesia. The electrocardiogram, oxygen saturation and expiratory CO2 were monitored continuously (Pulsoxi satlite plus and a Normocap CO2 monitor, Datex instruments Corp., Helsinki, Finland). For artificial respiration with room air, enriched with oxygen to 30%, we used a respiration pump (model 66 IA, Halrvard Apparatus, South Natick, Mass.). Oxygen saturation > 94% and tidal expiration of 4% CO2 was maintained throughout the anaesthesia. Body temperature (38-39°C) was regulated by a heating pad and monitored by a rectal probe. Sodium chloride infusion (0.9%, 10 ml/kg/hr) and occasionally Macrodex 70 (6%) were used to maintain fluid and electrolyte balance. Prior to enucleation of the first eye, we injected heparin for anticoagulation (Liquemin, 1000U/ml/kg, Roche, Basel, Switzerland), and immediately after enucleation a corresponding amount of protamine hydrochloride i.v. (1000 U/ml/kg, Protamin 1000, Roche, Basel, Switzerland).
Surgery and perfusion
After atropine-and phenylephrine-induced mydriasis the eye was enucleated in deep anaesthesia. Following cannulation of the ophthalmociliary artery, the eye was perfused with oxygenated (pO2 400-450 mm Hg) tissue culture medium TC 199, modified with Earle's salts and L-glutamine, 200 mM (Bio Concept, Allschwil, Switzerland), amikacin-sulphate (63.9/~M; Amikin, BristolMyers Squibb AG, Baar, Switzerland) and newborn calf serum (30%). The perfusate was buffered with HEPES (15 mmol/1) and NaHCO3 (26 mmol/l). The pH of the filtered (Millipore, 0.22/~m pore size) perfusate was adjusted to 7.4 and the temperature was maintained at 37°C. Oxygenation of the perfusate was done by bubbling with 95% 02 and 5% CO2 for 25 min at a rate of 150 ml/min.
Stimulation and electrical recording
The d.c. ERG was recorded with an intravitreal salt bridge electrode and a similar reference electrode on the scleral surface at the posterior pole of the eye. The monophasic negative compound action potential of the optic nerve, the light-evoked ONR, reflecting the summed activity of ganglion cells conducted by the axons, was recorded with Ag-AgCI electrodes: the position of the reference electrode was on the surface of the optic nerve, while the active (suction) electrode was placed on the proximal cut end of the optic nerve.
The light source for the stimuli was a 150 W xenon arc lamp providing a maximum of l l.541ogquanta [scot. 507 nm] deg -2 sec -1. The stimuli were applied with a modified fundus camera in Maxwellian view (Gouras & Hoff, 1970) . Attenuation of the light flashes was performed with neutral density filters and monochromatic filters to achieve rod matched conditions in full dark adaptation. The duration of the stimulus was 400 msec with an interval of 60 sec. For the stimulation of the cone system, an adapting beam (white background; 2 1 8.6 log quanta [scot. 507 nm] deg-sec-attenuated by 2.0-3.0 log units) was switched on to suppress the rod contribution, and white flashes were attenuated by 1.0-2.0 ND to elicit cone-driven responses. At the beginning of the electrophysiological recordings, immediately after the onset of perfusion, 20 msec standard red light pulses (delivered at 30 see intervals) were used to monitor the increase in sensitivity during dark adaptation for at least 60 min. The perfusion rate was adjusted (1-2.5 ml/min) until the b-wave reached an amplitude of 700-800/~V. Since some dead space within the perfusion system resulted in a delay betwe,en the beginning of an injection and first effects (on standing potential, flow rate or signal size) we chose to desigvLate "zero time" in all illustrations as the last point in lime before the onset of the first effect. This should improve clarity and the possibility to compare effects. Howeuer, exact times after start of injections are listed in Table 1 . Series with marked changes in flow were listed in the table, and marked separately in the illustrations that show maximal effects vs concentration of the cholinergic agents.
Agents
Several drugs were chosen to study cholinergic effects on the flow rate of the perfusate, the b-wave of the ERG and the ONR: as cholinergic agonists, ACh (acetylcholine chloride) and carbachol (carbamylcholine chloride) were applied in concentrations of 18-1600/aM (14 series, 5 eyes) and 20-80/aM (nine series, 4 eyes), respectively (Sigma, St Louis, MO, LI.S.A.).
As cholinergic antagonists, quinuclidinylbenzilate (QNB) (gift from Dr H. Bittiger, Research and Development Department of the Pharma Division, Ciba Geigy, Basel, Switzerland) and scopolamine (scopolaminhydrobromide, Sigma, St Louis, MO, U.S.A.) were applied in concentrations of 55-1613/aM (three series, 3 eyes) and 200-1000/aM (10 series, 3 eyes) respectively. The nicotinic antagonist m,ecamylamine (mecamylamine-HC1, provided by Merck, Sharp and Dohme Research Laboratory, Rahway, NJ, U.S.A.) was applied in concentrations of 120-1000/aM (12 series, 5 eyes). QNB and carbachol were used mainly in preliminary studies and their effects are not included in detail in this report.
RESULTS

Effects of ACh on the b-wave
As shown in Fig. I(A) , ACh enhanced the rod-driven b-wave. During the intra-arterial injection ACh (18-1600/aM) induced a clear, although variable increase in the b-wave amplitude. The increase ranged from + 7% to + 111% and was seen in six out of eight series. 
Effects of muscarinic and nicotinic antagonists on the b-wave
The decreasing action of the muscarinic antagonist scopolamine on the rod-driven b-wave is illustrated in Fig. I (B): 210 #M had only weak effects (-5%), while higher concentrations caused a decrease in b-wave in a range of -22% (500 pM) to -39% (1000 #M). The maximal effects of scopolamine on b-wave revealed an indication of dose relation except for 200/aM (roddriven) vs 230/aM [cone-driven; Fig. 3(B) ]. Incremental steps of 200 and 400/aM scopolamine induced an increase in rod-driven b-wave amplitude by 39% and 65%, respectively. However, this increase in b-wave was not reproducible in further experiments.
The nicotinic antagonist mecamylamine, in contrast, had biphasic effects on the rod-driven b-wave during the injection inducing a decrease in amplitude of the roddriven b-wave (-10% to -65%), frequently followed by a rapid increase (Fig. 1) . The increase was most obvious with concentrations of 500/aM mecamylamine (+ 30%), and the threshold dose was around 120/aM. Three series of mecamylamine (one eye) revealed a maximal decrease between 40% and 60%. However, an accompanying decrease in the flow rate by about 22-30% may be responsible in these particular series, since reduction in flow rate of perfusion decreases the amplitudes of light-evoked signals. Depressant effects of scopolamine on the b-wave amplitude were observed under both rod-and conestimulus conditions, and were more pronounced in the latter (Fig. 3) . Depressant effects of mecamylamine on the conedriven b-wave were observed in the range of 22-100%. A maximal depressant effect on the cone-driven b-wave was induced at concentrations of 200 and 500 #M. The decrease in b-wave amplLitude was followed by a rapid increase of 28-340% at concentrations of 500, 944 and 1000/zM (n=3; Fig. 2) . Interaction with the flow decreasing effects of mecamylamine is considered in interpreting this complex response pattern.
Effects of ACh on the ONR
Original traces and amplitude over time plots, reflecting changes in ONR amplitude to illustrate the effects of cholinergic agents are shown in Figs 4-7. The controls in Fig. 4 represent typical ONRs: during the onset of a 400msec light stimulus the initial ON-component appears, followed by a plateau, representing mainly tonic ganglion cell activity. 'Ihe OFF-component, following the termination of the stimulus, showed more variability than the ON-component and the plateau, due to expected complex interaction of the many types of ganglion cell firing patterns (Niemeyer, 1989) .
The effects of cholinergic agonists on the rod-matched ONR are shown in representative examples in Fig. 4(A) . At the beginning of the injection, the ON-component often increased temporarily (5-10%; Figs 5 and 7) before exhibiting a long lasting, marked decrease in amplitude. Configurational examination revealed that ACh induced a more pronounced decrease in the OFF-component (50-95%) than in the ON-component (8-40%). However, the OFF-component was not always distinct and measurable at the low stimulus intensity used here. The effects of ACh also comprised a decrease in the initial plateau phase (Fig. 8 ). Preliminary studies with carbachol revealed a more pronounced depression of the plateau, while the OFF-component showed a smaller decrease than seen with ACE l_~wer concentrations of carbachol increased the ON-component [ Fig. 4(A) ]. As shown in Fig. 5 , we recorded a small transient increase (5-10%) in the ON-component in four rod-driven series, as well as in two cone-driven series (Fig. 6) followed by a long lasting decrease (Table 1) .
This effect of ACh, representing a decrease in the roddriven ON-component, was observed in each series (n = 8). The changes in the ONR ON-component are summarized in Fig. 7 . The maximal ACh-induced decrease was observed at low concentrations (-40%), while higher concentrations had less depressant effects.
The effects of ACh on the cone-driven ONR are represented in original traces in Fig. 4(B) . ACh induced changes similar to those seen under rod stimulus conditions. Figure 7 includes the effects of ACh on the ON-component of the cone-driven ONR, with a maximal decrease of -5% to -17% (n = 6). As shown in Fig. 6 , an initial increase of + 2% to + 8% was observed in two out of six series.
In summary, the effects of intra-arterially applied ACh revealed characteristic time-courses. The effects appeared first as an enhancement of the b-wave while the ONR ON-and OFF-components decreased. Recovery was seen first in the b-wave. The ONR ON-component usually recovered within 60 min of the beginning of ACh injection. The OFF-components were decreased more than the ON-components. The b-wave increased more under cone than under rod stimuli, while the ONR decreased more under rod than under cone stimuli.
Effects of muscarinic and nicotinic antagonists on the ONR
Typical effects of cholinergic antagonists on the rodmatched ONR are shown in Fig. 4(A) . This illustrates the late effects of scopolamine decreasing the ON-components, while a pronounced augmentation of the plateau and the OFF-components was typically found. These effects were also observed under administration of the muscarinic antagonist QNB in preliminary studies, seen as an early effect in Fig. 4(A) . Furthermore, the ONcomponent, plateau and OFF-component were strongly depressed by QNB (late effect). Figure 5 depicts, in amplitude vs time plots, a dose-dependent, transient increase, and then a decrease in the ON-component induced by scopolamine in concentrations of 210-1000/zM. The decrease was observed immediately after stopping the injection. However, scopolamine transiently induced an increase in the ON-component during ---) . ACh (A): a dose-rdatod response was apparent only for the cone-driven b-wave. It was increased further in response to ACh than the rod-driven b-wave. Scopolamine (B): a dose-dependent relation was apparent for both rod-and cone-driven b-wave. An increase in rod-driven b-wave in response to scopolamine (200-400 #M) was recorded in one eye, while the other series clearly showed a decrease in response to scopolamine. The cone-driven b-wave was more decreased than the rod-driven b-wave. Mecamylamin¢ (C): the b-wave was decreased under both rod and cone stimulation. A biphasic effect of mecamylamine on the b-wave was observed in five series (arrows): a decrease in cone-driven b-wave followed by an increase was recorded in three series. Two series (one roddriven, one cone-driven) represent an increase in b-wave followed by a decrease. Effects of cholinergic agents on the cone-drivan b-wave. The time-course of changes in normalized amplitudes of the cone-driven b-wave was plotted in response to ACh (A), to scopolamine (B) and to mecamylamine (C). The changes were plotted as a percentage of control values (100%). ERGs were evoked every 60 sec by 400 msec flashes of white light, attenuated by 1-2 log units with neutral density filters. A rod suppressing white background was switched on. ACh (18-1600/zM) was injected for 10-25 rain and induced an increase in the b-wave up to 400%. Scopolamine (200-1000 #M) was injected for 10-30 min and induced a decrease in the b-wave by 20-80%. Mecamylamine (200-1000 #M) was injected for 10-15 min. The b-wave clearly decreased by up to 100% and increased by up to 350%. . ACh (18-1600/aM) was injected for 10-35 min and induced a transient increase followed by a decrease in ON-component by 40%. Scopolamine (210-1000/aM) was injected for 17 min. 210 and 500/aM revealed an initial increase followed by a small decrease during injection. 1000/aM clearly induced an increase by up to 20% during injection. The ON-component was remarkably decreased by 70% immediately after termination of the injection. Mecamylamine (120-1000/aM) was injected for 10-17 min. The ON-component was changed with large variability, but configurational changes were more reproducible [ Fig. 4(A, B) ]. injection by 6-20% (500 and 1000 #M). The maximal effects of scopolamine during injection in Fig. 7 reveal a threshold dose of about 200 #M, which had only weak effects on the ON-component (20 and 40 #M had no effect; not shown). Mecamylamine, in contrast, showed more variability on the rod-driven ONR in comparison to the muscarinic antagonist (Figs 5 and 7) . 120pM mecamylamine revealed only a slight decrease by 10%, while concentrations of 220-1000 pM induced a decrease in the ONR ON-components by --40% to -52% (Fig. 7) . The increase in the plateau was similar to that seen under scopolamine [ Fig. 4(A) and Fig. 8 ]. The OFF-component showed much variability under mecamylamine. Figure 4 (B) also illustrates effects of mecamylamine on the cone-driven ONR: 500 and 944/~M clearly increased the ON-component and the plateau of the cone-driven ONR, in contrast to the corresponding changes under rod stimulus conditions. The maximal increase in the ON-response was about 40%, occurring with a delay after termination of the injection in concentrations of 200 and 500 #M. 1000 pM decreased the ON-component of the cone-driven ONR by 12% without recovering completely. The OFF-component, exhibiting more variabilky, was decreased under mecamylamine.
Cholinergic effects on the magnitude of the ONR-plateau
Typical effects of cholinergic agents on the ONRplateau are shown in Fig. 8 . Cholinergic agonists [ Fig.  8(A) ] decreased the plalleau. Antagonists, in contrast, induced a pronounced augmentation of the plateau [ Fig.  8(B) ]. As shown in representative examples [ Fig. 8(A) ] ACh, applied for either 10 or 25 min, decreased the plateau under both cone and rod stimuli by 55% and 30%, respectively. Under rod-stimulus conditions carbachol induced a stronger decrease in the plateau than ACh, but under cone-stimulus conditions carbachol had weaker effects than ACh. The plateau decreased by 40% in response to incremental concentrations of carbachol.
Cholinergic antagonists affected the plateau in an opposite manner. Effects of scopolamine are shown in representative examples in Fig. 8(B) with incremental steps of 20(0-400 #M. Rod-driven signals revealed an increase in the plateau by 110%. Mecamylamine had a weaker effect on the plateau, inducing an increase by 60%. With cone stimuli both scopolamine and mecamylamine revealed similar effects, inducing an increase in plateau by 60%. The effects of cholinergic agents on the plateau of the ONR (maximal changes in %) are plotted against concentrations in Fig. 8(C) . Agonists occasionally increased the plateau transiently prior to a more pronounced decrease (arrows). The antagonists, in contrast, increased the plateau consistently.
Side effects of cholinergic agents on the flow rate of the perfusate
Cholinergic agonists. An increase in flow rate, reflecting a decrease in vascular resistance of the perfused eye was observed in 13 out of 16 series. ACh increased flow rate in a range of 2-15%, while the flow remained unchanged in three series.
Cholinergic antagonists. Scopolamine and mecamylamine consistently induced a decrease in the flow rate, corresponding to an increase in vascular resistance. In every case the muscarinic (scopolamine) and nicotinic (mecamylamine) antagonists decreased the flow rate in a range of 4-15%. In one preparation (three series) mecamylamine (220-515 pM) induced unusually large flow decreases of -22% to -30%.
Changes in flow rate induced by the applied agents (Jurklies, Kaelin & Niemeyer, 1994) can per se affect the magnitude of the light-evoked responses in the perfused eye. Therefore the effects of substantial changes in flow rate must be considered in evaluation of electrophysiological data. Where this appeared not feasible we excluded the respective series from the summary graphs.
DISCUSSION
It was found that cholinergic agents affected differentially the ERG b-wave and selective components of the optic nerve compound action potential, ONR. These effects will be discussed separately.
Cholinergic agonists and b-wave
The ACh-induced effects on the b-wave consisted of an enhancement of rod-and cone-driven b-waves, which is in part in agreement with previous studies in the cat in vivo (von Bredow, Bay & Adams, 1971) and in the isolated rabbit retina (Honda, 1971) . These authors concluded that increased concentrations of ACh in retinal synapses are responsible for the increase in b-wave amplitude. It seems conceivable that enhancement of the b-wave amplitude expresses feedback on bipolar cells, i.e. via amacrine cells (Linn & Massey, 1992; Neal & Cunningham, 1994) .
Any increase in amplitude of light-evoked retinal signals can be related to an increase in blood-or perfusate-flow. An increase in flow rate increases the oxygen supply and can enhance the b-wave in vitro (Niemeyer, 1973) . Demant, Nagahara and Niemeyer (1982) reported a stability of the b-wave after changing mean arterial blood pressure between 55 and 225 mm Hg in the anaesthetized cat, but the b-wave decreased rapidly when the mean arterial blood pressure was lowered below 55 mm Hg. This wide range of stability of the b-wave was considered to reflect an autoregulation of the blood supply to the retina, which keeps neural functions constant. According to these findings on flow effects on the ERG, the ACh-induced changes in the present study cannot be explained by the relatively small changes in flow rate. Furthermore, the effects of several cholinergic agents affected rod-driven and cone-driven signals differently. If an increase in flow rate is responsible for the Ach-induced changes in b-wave amplitude, both the rod-and cone-driven b-wave would be affected equally by the change in flow rate. This applies as well to the effects on the ONR (see below). The effects of ACh on the cone b-wave compared to those on the rod b-wave suggest that ACh has stronger effects on the cone pathway than on the rod pathway within the inner nucelar ]layer. That might be related to the following facts: (i) cone bipolar cell connections to cholinergic amacrine cells (starburst or A14 amacrine cell) (Pourcho & Osman, 1987) were reported by Famiglietti (1983) ; (ii) the density of cholinergic amacrine cells is highest in the central part of the cat retina (Schmidt et al., 1987) corresponding to the higher cone density; (iii) Vivas and Drujan (1980) found that the ACh release in light-adapted teleost retinae was 50% higher than in dark-adapted retinae.
Several authors demonstrated that cholinergic markers, including high affinity c]~oline uptake, choline acetyltransferase, acetylcholinesterase, as well as bungarotoxin and muscarinic binding sites are all present in the proximal mammalian retina (Neal, 1983; Puro, 1985; Pourcho & Osman, 1987; Schmidt et al., 1987) . Our results suggest that cholinergic mechanisms also affect structures that contribute to the b-wave, modulating the cone-driven more than the rod-driven signals. Several findings suggest a possib]Le cholinergic effect on the bwave via Miiller cells: Hfsli, H6sli, Maelicke and Schr6der (1992) and H(isli, H6sli and Kaser (1993) detected cholinergic receptors on astrocytes, and they recorded electrophysiological responses mediated by muscarinic receptors in cultured astrocytes. Acetylcholinesterase has been located in the teleost retina (Nichols, Hewitt & Laties, 1972) . Therefore, an effect of cholinergic agents on the retinal glia, the Mtiller cells, is conceivable via its response to changes in light-evoked increases in extracellular potassium concentration at the outer border of the inner nuclear layer. This mechanism is the prevailing concept for the generation of the ERG bwave (Newman, 1985; Wen & Oakley, 1990) . However, recent pharmacological separation of components presumably contributing to generation and termination of the b-wave indicate complex contributions from ON-and OFF-bipolar cells as well as from horizontal cells (Sieving, Murayama & Naarendorp, 1994) . This aspect and the notion that cat S-potentials are not affected by cholinergic agents (Niemeyer, Albani & Schuurmans, 1981) do not preclude the possibility of influences of cholinergic amacrine cells on the b-wave via feedback connections to rod and cone bipolar cells, that in turn would influence the membrane potential of Miiller cells. Based on this view one would expect different effects of cholinergic agents on the ERG compared to the ONR, as revealed by the present results.
Cholinergic antagonists and b-wave
Scopolamine and mecamylamine mainly induced a decrease in b-wave amplitude, a change opposite to the effects of ACh. These results are in part in agreement with a previous study of Niemeyer and Cervetto (1977) , who observed a biphasic effect, a transient increase followed by long lasting decrease, after intra-arterial administration of atropine in the perfused cat eye. In contrast, in vivo studies of the cat (von Bredow et al., 1971) and in vitro studies of the isolated rabbit retina (Nakagawa, Kurasaki, Masuda, Ukai, Kubo & Kadono, 1988) revealed an increase in b-wave amplitude after administration of atropine. We observed a clear, scopolamine-induced increase in b-wave amplitude only in one preparation, and this increase was not reproducible in further experiments. Differences in drug application (yon Bredow et al., 1971) and in the experimental setup (Nakagawa et al., 1988) may explain this disaccord.
While the effects of scopolamine imply a specific antagonistic action, changes in cone-driven b-wave during injection of mecamylamine do not fit completely in the agonist/antagonist concept. It is conceivable that the accompanying decerase in flow rate induced by mecamylamine produced the initial and probably underlying decrease in b-wave, that affected to a varying extent the longer lasting "neural" increase in b-wave amplitude. The decrease in b-wave amplitude was followed by a marked increase under cone stimulus conditions. Nonspecific effects in the present study may be responsible for these incomplete antagonistic actions of mecamylamine on the cone-driven b-wave. Nonspecific effects of the nicotinic antagonist dihydrobetaerythroidine were reported by Schmidt et al. (1987) , who suggested that the effects may be mediated either via nonspecific binding sites or via binding on inhibitory interneurons.
The different effects of scopolamine compared to those of mecamylamine for rod vs cone stimuli point to a different role of muscarinic vs nicotinic receptors: Honda (1971) suggested that cholinergic transmission in the rabbit's retinal synapses is muscarinic rather than nicotinic. Our results on mecamylamine on the roddriven b-wave are indicative of muscarinic as well as The plateau of both the rod-and cone-driven ONR was decreased in response to cholinergic agonists (A): ACh (400-800/aM, square) and carbachol (24-48 #M, diamond) injected for 25 and 12 min induced a decrease in plateau of the roddriven ONR by up to 30% and 20%, respectively. ACh and carbachol were applied continuously and injected using incremental concentrations. Concentrations of 400/~M ACh for 10 min revealed similar effects on plateau of the cone-driven ONR corresponding to a decrease up to 55%. (B) Cholinergie antagonists induced an increase in plateau of both the rod-and conedriven ONR: the plateau of the rod-driven ONR was increased by up to 65% and 110% in response to 200--400 pM scopolamine, and to 500 pM mecamylamine that was injected for 22 and 14 rain, respectively. (C) Maximal changes in normalized amplitudes of the ONR plateau in relation to the concentration of cholinergic agents, where open symbols represent agonists and solid symbols antagonists. Several incremental concentration series are included as separate data points. A dose-response relation is apparent for ACh and carbachol. An initial small increase followed by a long lasting decrease (arrow) was observed for three out of seven concentrations of cholinergic agonists. The main effect of agonists was a decrease in the ONR plateau. The antagonists scopolamine and mecamylamine (solid symbols) consistently induced an increase in the plateau.
nicotinic transmission in the dark-adapted cat eye. In accordance with the effects of ACh on the cone-driven bwave, the action of scopolamine was stronger on the cone-than on the rod-driven signals. However, the nicotinic antagonist mecamylamine was not more effective in the cone-driven compared to that on the rod-driven b-wave.
Cholinergic agonists and' ONR
ACh consistently induced a decrease in the ONR components, frequently preceded by a brief initial increase in the ON-component. The decrease of ONRcomponents was observed in spite of a simultaneous increase in flow rate (that per se would tend to increase the signal size). This observation provides evidence that the cholinergic effects represent a distinct interaction with neural receptors in addition to glial (see above) and vascular effects. ACh attenuated the plateau-and OFFcomponents more than the ON-component. This attenuation of the ONR-plateau is likely to reflect inhibition of sustained ON-centre ganglion cell activity (Gerber & Niemeyer, 1988) . Supporting evidence for inhibition of ON-centre ganglion cells by ACh is provided by single cell recordings of previous studies in the cat (Straschill, 1967; Straschill & Perwezin, 1973) . Related observations are provided by single cell recordings of a study by Ikeda and Sheardown (1982) , who reported that ACh suppressed the spontaneous firing (maintained discharge) of sustained ON-cells and enhanced that of sustained OFFcells. ACh in the present experiments decreased the ONR-ON component, whLich may indicate some inhibition of ON-centre cell activity. However, Schmidt et al. (1987) , reported an increase in maintained discharge of the retinal ganglion cell responses, including X-, Y-and sluggish cells. In their study ACh induced an increase in the light-evoked activity during centre, surround and whole-field stimulation, and ON-centre X-cells only were affected using low concentrations of ACh (100 pM). However, their experimental approach differs from the perfused cat eye, where intra-arterially injected ACh should reach all cholinergic sites in the retina approximately at the same time. Thus, several factors may explain the varying restdts of single cell recordings (Straschill & Perwein, 19'73; Ikeda & Sheardown, 1982; Schmidt et al., 1987) compared to our study: (i) the use of different techniques, e.g. iontophoretic vs intra-arterial drug application and (ii) the use of mostly higher concentrations of ACh oampared to our study. Iontophoretic application of an agonist or antagonist to a single ganglion cell appears to :reflect changes different from those seen in the ONR that reflect rather effects on the neuronal network distal to the ganglion cells.
The ONR thus is understood to comprise the firing patterns of all participating axons from all types of ganglion cells in the cat retina, reflecting both, excitation and inhibition (Niemeyer, 1989) . The drug-induced changes are interpreted as alteration of the balance between excitatory and inhibitory events reflecting the "retinal output". The initial increase and the subsequent decrease of the ONR ON-component during ACh application may reflect the effects of ACh on both excitatory and inhibitory synapses. This biphasic ACh effect, excitation followed by inhibition, was also observed in cortical and brainstem neurons (Bradley, Dhawan & Wolstencraft, 1966; Crawford & Curtis, 1966) . This may provide evidence for an initial excitatory ACh effect followed by an indirect, GABA-mediated inhibitory effect on the ONR: cholinergic amacrine cells have been shown to contain and release GABA (Chunn, W/issle & Brecha, 1988) . Linn and Massey (1992) suggested that GABA may inhibit the light-evoked ACh release via negative feedback onto bipolar cell terminals. Therefore, the cholinergic and GABAergic amacrine cell may provide a feedback circuit, activated whenever the ACh concentration exceeds steady-state levels. Evidence for this regulatory mechanism via negative feedback might be expressed in our results, where the major effect of ACh was a decrease in the ONR components.
Cholinergic antagonists and ONR
The muscarinic antagonist scopolamine dearly revealed biphasic effects on the ONR-ON component under both rod-and cone-selective stimulation. This can be interpreted as a competitive interaction with endogenous ACh on cholinergic receptors: the ON-component of the rod-driven ONR was transiently enhanced, while inhibitory effects were maximal following the end of drug administration. The increase in the plateau was also observed under administration of the muscarinic antagonist QNB in preliminary studies (Niemeyer, Jurklies, Kaelin-Lang & Bittiger, 1995) , implying a specific action on the muscarinic receptor. An earlier study on effects of atropine on the perfused eye also revealed a dosedependent attenuation of the ONR (Niemeyer & Cervetto, 1977) .
The inhibitory effect of scopolamine on the ONR corroborates earlier recordings from ganglion cells: intraarterial application to perfused cat eyes of the muscarinic antagonist atropine induced a depression of both, ON-and OFF-centre cells in their light-evoked centre response as well as in their maintained activity . Schmidt et al. (1987) observed a decrease in stimulus induced and maintained firing of the studied ganglion cell types in response to iontophoretically applied scopolamine (100/~M). However, in the present study we observed a remarkable and reproducible depression of the ONR-ON component immediately after stop of scopolamine injection. Other mechanisms may be responsible for these anticholinergic effects: antagonists could potentiate ACh release possibly due to the block of autoreceptors (Kilbinger, 1989) or due to an feedback to cholinergic amacrine cells involving glycinergic interneurons (Cunningham, Dawson & Neal, 1983) . Muscarine enhanced the release of glycine from amacrine cells, while atropine reduced this release of glycine and enhanced the release of ACh in their study. Neal and Cunningham (1994) suggest that muscarinic receptors on glycinergic amacrine cells are blocked by antagonists,
